Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Biochips Market Expected to Grow Between 2025 And 2029?

The biochips market has seen swift expansion in the last few years. The anticipated growth is from $12.62 billion in 2024 to $14.72 billion in 2025, representing a compound annual growth rate (CAGR) of 16.6%. Factors contributing to this historic growth can be linked to the rising demand for personalized medicine, an increased number of chronic disease cases, technological advancements, a wider scope of applications in drug discovery, a surge in research and development investments, and supportive regulations.

What Growth Rate Is Anticipated for the Biochips Market in the Coming Years?

The market size of biochips is anticipated to experience swift expansion in the subsequent years. The market is projected to grow to a value of $26.94 billion by 2029, with a compound annual growth rate (CAGR) of 16.3%. The projected growth within the forecast period can be linked to the escalating adoption in point-of-care diagnostics, widespread use in drug development, growing demand for personalized medicine, enhancement in microfluidics technology, elevated research and development investments, increased collaborations between biotech firms and academic bodies, and new prospects in agricultural biotechnology. Key trends within the forecasted period consist of microfluidics technology advancements, focus on creating biochips for liquid biopsy applications, increasing need for multiplexed assays for simultaneous detection of multiple analytes, the application of artificial intelligence for data assessment, and the development of innovative biochip platforms.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15737&type=smp

Who Are the Leading Companies in the Biochips Market?

Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Zoetis Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., Partek Incorporated, NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV

What Are the Key Drivers of the Biochips Market?

The biochips market is expected to expand due to the rising incorporation of personalized medicines. Personalized medicine aims to adjust medical procedures according to individual attributes such as lifestyle or genetic makeup to maximize effectiveness and reduce negative effects. The escalating demand for personalized medicine originates from its proficiency to offer more efficient treatments, advancements in genomics, growing complexity of diseases, and regulatory endorsement. Biochips facilitate personalized medicine by providing accurate and personalized treatment strategies based on an individual’s genetic makeup. Case in point, the Personalized Medicine Coalition, a non-profit entity based in the United States, reported in February 2024 that the FDA had approved 16 innovative personalized therapies for rare disease patients in 2023 as opposed to six in 2022. Therefore, the growing acceptance of personalized medicines is boosting the growth of the biochips market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15737&type=smp

What Are the Key Market Segments in the Biochips Industry?

The biochips market covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays

2) By Technology: Microarrays, Microfluidics

3) By Application: Drug Discovery And Development, Agriculture, Genomics, Disease Diagnostics, Proteomics, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Companies, Academic And Research Institutes, Hospitals And Diagnostic Centers, Other End-Users

Subsegments:

1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips, Snp (Single Nucleotide Polymorphism) Chips, Dna Microarrays

2) By Protein Chips: Antibody Arrays, Protein Microarrays, Peptide Arrays

3) By Lab-On-Chip: Microfluidic Devices, Biosensors

4) By Tissue Arrays: Tumor Tissue Arrays, Normal Tissue Arrays

5) By Cell Arrays: Cell-Based Biochips, Cell Signaling Arrays

What Are the Latest Trends in the Biochips Market?

Leading biochips market players are focusing their resources on ground-breaking technologies such as organ-on-a-chip platforms, which aim to transform the processes of drug discovery and development. The organ-on-a-chip platforms are sophisticated microfluidic devices designed to mimic the physiological attributes and functions of human organs on a smaller scale. For example, BMF, a nanotechnology research firm based in the US, unveiled BMF Biotechnology Inc. in April 2024. BMF Biotechnology Inc. is dedicated to biochips, also known as organ-on-a-chip platforms, which are made to foster large-scale tissue growth in vitro. This advancement expedites the production of new drugs and cosmetics by offering a platform for research and testing outside the human body.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biochips-global-market-report

What Are the Key Regional Markets in the Biochips Industry?

North America was the largest region in the biochips market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15737

This Report Delivers Insight On:

1. How big is the biochips market, and how is it changing globally?

2. Who are the major companies in the biochips market, and how are they performing?

3. What are the key opportunities and risks in the biochips market right now?

4. Which products or customer segments are growing the most in the biochips market?

5. What factors are helping or slowing down the growth of the biochips market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model